Tags : Interstitial Cystitis/Bladder Pain Syndrome

Purdue Pharma Signs an Agreement with Alivio Therapeutics for its

Shots: Alivio to receive $14.75M upfront, $260M milestones, license exercise payments and royalties on sales of product from Purdue. Purdue to get an option to add more compounds to the agreement based on Alivio’s inflammation-targeting technology, including an option for equity investment in Alivio The company received funding of $3.3M from the US DOD Technology/Therapeutic […]Read More